BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4444662)

  • 1. [Hypofibrinolysis in acute myocardial infarction (author's transl)].
    Bruhn HD; Jipp P; Okoye S; Oltmann A
    Med Klin; 1974 Nov; 69(47):1951-5. PubMed ID: 4444662
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic activity and coronary-artery disease.
    Chakrabarti R; Hocking ED; Fearnley GR; Mann RD; Attwell TN; Jackson D
    Lancet; 1968 May; 1(7550):987-90. PubMed ID: 4171834
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
    Menon IS
    Acta Univ Carol Med Monogr; 1972; 52():19-23. PubMed ID: 4669824
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenformin and ethyloestrenol in recurrent deep venous thrombosis (DVT).
    Hedner U; Nilsson IM; Isacson S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):372-80. PubMed ID: 63424
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyperfibrinogemia following activator therapy].
    Zawilska K; Jazienicki B
    Acta Haematol Pol; 1972; 3(1):53-8. PubMed ID: 4119480
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on blood coagulation and fibrinolytic activities in the three cases of cerebral infarction treated with urokinase. 1st report--120,000 I.U. administrated-- (author's transl)].
    Fujita S; Itoga T; Shou T; Yamamoto H; Ishikawa H
    Rinsho Ketsueki; 1978 Jun; 19(6):850-8. PubMed ID: 713046
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinolytic activity and coronary-artery disease.
    Naimi S; Proger S
    Lancet; 1968 Jun; 1(7554):1250-1. PubMed ID: 4172804
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of fibrinolysin with heparin and thrombolytin on blood coagulation indices in myocardial infarct patients with thromboembolic complications].
    Panchenko VM; Dmitrieva ZA; Pastorova VE
    Ter Arkh; 1971 Aug; 43(8):95-9. PubMed ID: 4261359
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on blood coagulation and fibrinolytic activities in the cases of cerebral infarction treated with urokinase. 2nd Report -- espeically changes of coagulofibrinolytic system before and after UK infusion (author's transl)].
    Fujita S; Shou T; Yamamoto H; Ishikawa H; Itoga T
    Rinsho Ketsueki; 1979 Jul; 20(7):745-53. PubMed ID: 501999
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenformin plus ethyloestrenol in survivors of myocardial infarction. Three-year pilot study.
    Chakrabarti R; Fearnley GR
    Lancet; 1972 Sep; 2(7777):556-9. PubMed ID: 4115736
    [No Abstract]   [Full Text] [Related]  

  • 11. [Variations in hemostasis and fibrinolysis during the treatment of acute myocardial infarct (AMI) with tissue-type plasminogen activator (TTPA). A study of 17 cases].
    Izaguirre Avila R; Ruiz de Chávez Cervantes A; Villavicencio R; Gómez Trigos A; Mar Chavira R; Spíndola Mdel C; Casanova JM
    Arch Inst Cardiol Mex; 1993; 63(3):235-40. PubMed ID: 8347053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective fibrinolytic states as triggers of myocardial infarction: the cardiologist's view.
    Huber K
    Ital Heart J; 2001 Sep; 2(9):646-51. PubMed ID: 11666090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
    Nilsson IM; Isacson S
    J Clin Pathol; 1972 Jul; 25(7):638-9. PubMed ID: 5070268
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological stimulation of fibrinolytic activity in the surgical patient.
    Brown IK; Haggart B; Murray GH; Downie RJ; Littler J; Robb PM; Santer GJ
    Lancet; 1971 Apr; 1(7703):774-6. PubMed ID: 4101274
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrinolytic treatment of acute myocardial infarction (author's transl)].
    Woitinas F; Begemann H
    Herz; 1981 Feb; 6(1):50-4. PubMed ID: 7216122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [When is fibrinolytic therapy indicated?].
    Woitinas F
    Med Klin; 1980 Feb; 75(3):98-107. PubMed ID: 6990218
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibrinolysis in myocardial infarct].
    Triolo R; Cavagnino A
    Cardiol Prat; 1971 Oct; 22(5):357-65. PubMed ID: 5136473
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological fibrinolysis after surgical operations.
    Lancet; 1971 Apr; 1(7703):789-90. PubMed ID: 4101283
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinolytic therapy for vasculitis of atrophie blanche.
    Gilliam JN; Herndon JH; Prystowsky SD
    Arch Dermatol; 1974 May; 109(5):664-7. PubMed ID: 4828532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.